Literature DB >> 18834857

The cell growth suppressor, mir-126, targets IRS-1.

Jin Zhang1, Ying-ying Du, Yi-feng Lin, Ya-ting Chen, Lu Yang, Hui-jun Wang, Duan Ma.   

Abstract

miRNAs are a family of approximately 22-nuleotide-long noncoding RNAs involved in the formation and progress of tumors. Since traditional methods for the detection of miRNAs expression have many disadvantages, we developed a simple method called polyA RT PCR. With this method, we detected a series of miRNAs and found that mir-126 is one of the miRNAs underexpressed in breast cancer cells. Flow cytometry analysis showed that mir-126 inhibited cell cycle progression from G1/G0 to S. Further studies revealed that mir-126 targeted IRS-1 at the translation level. Knocking down of IRS-1 suppresses cell growth in HEK293 and breast cancer cell MCF-7, which recapitulates the effects of mir-126. In conclusion, we developed a simple method for high-throughput screening of miRNAs and found that mir-126, a cell growth suppressor, targets IRS-1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834857     DOI: 10.1016/j.bbrc.2008.09.089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  104 in total

Review 1.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

2.  Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.

Authors:  Zhong-Bo Han; Lin Zhong; Mu-Jian Teng; Jun-Wei Fan; Hua-Mei Tang; Jun-Yi Wu; Hong-Yuan Chen; Zhao-Wen Wang; Guo-Qiang Qiu; Zhi-Hai Peng
Journal:  Mol Oncol       Date:  2012-04-17       Impact factor: 6.603

3.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

4.  Alteration of processing induced by a single nucleotide polymorphism in pri-miR-126.

Authors:  Ratanakanit Harnprasopwat; Daon Ha; Takae Toyoshima; Harvey Lodish; Arinobu Tojo; Ai Kotani
Journal:  Biochem Biophys Res Commun       Date:  2010-07-17       Impact factor: 3.575

5.  Fenretinide reduces angiogenesis by downregulating CDH5, FOXM1 and eNOS genes and suppressing microRNA-10b.

Authors:  Elif Isil Yücel; Mehmet Sahin
Journal:  Mol Biol Rep       Date:  2020-01-10       Impact factor: 2.316

6.  Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.

Authors:  Ghada Al-Kafaji; Harun Muayad Said; Mahmood Abduljalil Alam; Ziad Tarraq Al Naieb
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

7.  The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade.

Authors:  Xiao-Feng Le; Omar Merchant; Robert C Bast; George A Calin
Journal:  Cancer Microenviron       Date:  2010-02-23

8.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

9.  MicroRNA expression profiling of male breast cancer.

Authors:  Matteo Fassan; Raffaele Baffa; Juan P Palazzo; Joshua Lloyd; Marco Crosariol; Chang-Gong Liu; Stefano Volinia; Hannes Alder; Massimo Rugge; Carlo M Croce; Anne Rosenberg
Journal:  Breast Cancer Res       Date:  2009-08-10       Impact factor: 6.466

10.  Expression and function of the insulin receptor substrate proteins in cancer.

Authors:  Katerina Mardilovich; Shannon L Pankratz; Leslie M Shaw
Journal:  Cell Commun Signal       Date:  2009-06-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.